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ABSTRACT 
Thioredoxins function as general protein disulphide reductases. Mammalian male germ cells 
are equipped with a set of three testis-specific thioredoxins named Sptrx-1, -2 and –3, 
respectively. Sptrx proteins are expressed either in different structures within the sperm cell or at 
different stages of sperm development, suggesting a refined regulation in the timing and levels 
of expression for each Sptrx gene. Previous studies based on qualitative northern-blot and in situ 
hybridization analyses restricted the presence of Sptrx mRNAs to adult testis, but nothing is 
known about their transcriptional regulation or relative expression levels in this tissue.  
In this report we investigate the transcriptional profiles of the mouse Sptrx genes in terms of 
the germ cell-specific regulation by promoter analysis in GC-2spd(ts) cells. Besides, we perform 
a comprehensive quantification of the Sptrx mRNA molecules by real-time PCR in whole-
animal experiments. By these means, we show that transcription is differentially regulated for 
each Sptrx gene and identify the 5’-flanking regions anticipated to contain the cis-regulatory 
elements responsible, at least in part, for the transcriptional silencing and/or activation of the 
Sptrx genes. In addition we show remarkable age-associated variations between the Sptrx 
mRNA expression patterns. Finally we corroborate the testis-specific expression pattern of 
Sptrx-2 and Sptrx-3, but surprisingly we find a wider expression pattern for Sptrx-1  
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1. INTRODUCTION 
Cellular redox balance is maintained in living organisms by various non-enzymatic as well as 
enzyme-based systems [1]. Among them, thioredoxin (Trx) and related proteins have emerged 
as one of the most important thiol-based systems being involved in many physiological as well 
as pathophysiological processes [2]. The mammalian thioredoxin system consists of the 
hydrogen donor NADPH and the selenoprotein thioredoxin reductase (TrxR) coupled to the 
redox active protein thioredoxin [3, 4]. Eukaryotic organisms are equipped with two ubiquitous 
thioredoxin systems: a cytoplasmic one composed of Trx-1 and TrxR-1, and a mitochondrial one 
formed by Trx-2 and TrxR-2 [3, 5]. Moreover, different forms of thioredoxins and thioredoxin 
reductases with unique properties such as organelle- or tissue-specific localization have been 
reported [6-11]. In this regard, male germ cells are endowed with three testis-specific 
thioredoxins named Sptrx-1 [12, 13], Sptrx-2 [14, 15] and Sptrx-3 [16], respectively, thus 
reflecting a key role of this family of proteins in spermatogenesis. 
Sptrx-1 comprises one N-terminal repetitive domain of a 15 amino acid motif and one C-
terminal thioredoxin domain [12, 13] displaying both reducing and oxidizing activities [17]. 
Sptrx-1 is located in the developing tail of elongating spermatids, transiently associated with the 
longitudinal columns of the fibrous sheath. This transient association during sperm tail 
formation strongly supports a regulatory role of Sptrx-1 in sperm development [12, 13]. Sptrx-2 
is also a multi-domain protein composed by one N-terminal thioredoxin domain followed by 
three NDP-kinase domains [14, 15]. Sptrx-2 is associated with the longitudinal columns of the 
sperm fibrous sheath and also with the ribs that connect these two columns. Unlike Sptrx-1, 
Sptrx-2 becomes a structural part of the mature sperm tail and can be detected in ejaculated 
spermatozoa. Sptrx-2 could be involved in the reduction of disulfide bonds within the sperm 
fibrous sheath components [14, 15]. In contrast to Sptrx-1 and Sptrx-2, the Sptrx-3 gene codes 
for a unique thioredoxin domain and was originated as a genomic duplication of the Trx-1 gene 
[16]. Sptrx-3 is a Golgi apparatus-associated thioredoxin showing a transient association with 
the developing spermatid acrosome. Its function might be related to the post-translational 
modification of proteins required for acrosomal biogenesis [16].  
Spermatogenesis is a complex process leading to the formation of one haploid motile cell and 
the specific gene expression occurring through spermatogenesis must be tightly regulated and 
coordinated [18, 19]. Transcription initiation is a key regulatory step in the modulation of gene 
expression and involves the interaction of many transcription factors and cis-regulatory DNA 
elements [20]. During spermatogenesis, spermatogenic cell-specific genes are expressed as well 
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as spermatogenic cell-altered transcripts due to different transcription start sites usage, 
alternative polyadenylation or splicing and mRNA shortening or degradation [21]. As mentioned 
above, a rigorous regulation in the timing and levels of gene expression is required and likewise 
transcriptional initiation regulatory mechanisms, post-transcriptional regulatory pathways are 
crucial for spermatogenesis [22]. For example, transcriptional machinery is inactive in 
elongating spermatids due to the changes occurring in the chromatin structure and nuclear 
elongation; in contrast, pachytene spermatocytes and round spermatids are transcriptionally 
active and display very similar transcription rates [21]. Thus, some mRNAs are transcribed 
during pachytene spermatocyte or round spermatid stages and then stored as transcriptionally 
repressed free messenger ribonucleoprotein particles to be actively translated in elongated 
spermatids [21]. 
Here we report the first analysis of the mouse Sptrx-1, Sptrx-2 and Sptrx-3 gene transcription 
by characterizing their corresponding promoters and also by performing a meticulous 
quantification of their steady-state mRNA copy numbers.  
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2. MATERIALS AND METHODS 
2.1. Luciferase reporter constructs 
BAC clones RP23-291E22, RP23-332H6 and RP23-332H16 containing mouse Sptrx-1, 
Sptrx-2 and Sptrx-3 genomic regions respectively were obtained from BACPAC Resources 
Center (http://bacpac.chori.org/). All the Sptrx 5’-flanking regions were amplified by PCR using 
combinations of the mutagenic primers listed in Supplemental Data Table 1, which introduced 
unique restriction sites (MluI/XhoI for Sptrx-1 and Sptrx-3 and MluI/BglII for Sptrx-2) at the 5’ 
and 3’ ends, respectively. All the PCR products were first cloned into pGEM-Teasy (Promega) 
and subsequently verified by sequencing and comparison with sequences deposited at NCBI 
(http://www.ncbi.nlm.nih.gov/genome//guide/mouse/). Next, the Sptrx 5´-flanking regions were 
removed from the pGEM-Teasy constructs by restriction enzyme digestion and cloned into the 
promoterless firefly luciferase reporter vector pGL-3 basic (Promega).  
 
2.2. Cell Culture, transfections and luciferase assay 
GC-2spd(ts) (ATCC no. CRL-2196), Hepa1-6 (ATCC no. CRL-1830) and Y-1 (ATCC no. 
CCL-79) cell lines were obtained from the American Type Culture Collection. All media and 
supplements were purchased from Life Technologies. Cells were grown in Dulbecco’s Modified 
Eagle’s Medium (DMEM) at 37ºC or 32ºC in an atmosphere of 5% CO2. GC-2spd(ts) cells were 
supplemented with 1mM non-essential amino-acids. All media contained 10% fetal bovine 
serum (FBS) and 2mM L-glutamine. 
Transient transfections were performed in 24-well plates using Lipofectamine™2000 (Life 
Technologies) according to the manufacturer’s instructions. A total of 0.5µg to 1µg of DNA was 
used in each reaction. Cells were incubated for 48 hours before lysis and preparation of cellular 
extracts. Independent parallel transfections using exclusively the pEGFP-N3 vector (Clontech) 
were always included as additional control for transfection efficiency, measured as number of 
cells expressing GFP. 
Enzyme activity assays were performed to measure luciferase expression levels (Luciferase 
Assay Kit, Biothema AB, Sweden) using a Berthold FB12 luminometer (Berthold detection 
systems, Germany). 
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2.3. Animals 
Male BALB/c mice of 7 weeks of age were purchased from Charles River Laboratories 
(Spain). Mice of other ages were obtained through the “Servicio de Animales de 
Experimentación of Córdoba University”. Animals were individually killed by cervical 
dislocation. Testes were then removed and immediately frozen in liquid nitrogen. Mice were 
handled according to the policies and procedures stipulated by the European Community. The 
investigation was approved by the Ethical Committee of Córdoba University.  
 
2.4. RNA Preparations and Reverse Transcription 
RNA extraction and synthesis of standard RNA and cDNA were performed as described [23]. 
Commercial RNAs were purchased from Clontech, except for ovary total RNA that was 
obtained from Ambion. RNA sample quality was checked electrophoretically and quantification 
was performed spectrophotometrically. Lack of genomic DNA contamination was confirmed by 
PCR amplification of RNA samples without previous cDNA synthesis. 
 
2.5. Primer design for real-time PCR 
Primers were designed in silico using Oligo 6.1.1/98 software (Molecular Biology Insights). 
To obtain the highest specificity and performance, primers were required to have high Tm (≥ 
80°C) and optimal 3’ ∆G (≥ -6.7 kcal/mol) values. Several pairs of primers were designed for 
each Sptrx gene (Table 2). All primer pairs generated specific PCR products of the desired 
length. PCR products were further verified by nucleotide sequencing. 
 
2.6. Real-time PCR 
Real-time PCR conditions were as detailed [23]. PCR reactions were performed in 
quadruplicate. No primer-dimers were detected, and investigated transcripts showed optimal 
PCR efficiencies. An absolute standard curve was constructed with an external standard in the 
range of 102 to 109 RNA molecules. The number of mRNA molecules was calculated from the 
linear regression of the standard curve, as previously described [23]. 
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3. RESULTS 
 3.1. Sptrx mRNA and protein expression levels in GC-spd(ts) cell line 
Promoter analysis studies offer valuable information about transcriptional regulation during 
spermatogenesis. The identification of the cis-acting and trans-acting elements directing the 
spermatogenic-specific transcription of Sptrx genes is essential to shed more light onto their role 
in sperm physiology. However, a major limitation to this approach is the availability of adequate 
cell lines that can recapitulate different aspects of spermatogenesis. To our knowledge, GC-
spd(ts) is the only spermatogenic mouse cell line available, which is able to undergo meiosis in 
vitro and develop a primordial tail and acrosome when cultured at 32ºC [24]. To test whether the 
Sptrx genes are expressed in GC-2spd(ts) cells, we performed western-blot analysis on crude 
protein extracts from these cells grown at 37ºC and 32ºC, but we were unable to detect any of 
the three proteins (data not shown). As this result may only reflect the translational inactivity of 
the Sptrx transcripts, we followed to measure the actual numbers of Sptrx mRNA molecules in 
GC-2spd(ts) cells. In agreement with their protein levels, the Sptrx-2 and Sptrx-3 mRNAs were 
virtually absent (≤ 0.001 molecules/pg total RNA); however, although at very low levels, we 
succeeded to detect and quantify the Sptrx-1 transcript at both 37ºC (0.083 molecules/pg) and 
32ºC (0.457 molecules/pg). 
Overall, these data indicate that the GC-spd(ts) cell line has very low or undetectable Sptrx 
mRNA and protein levels suggesting that their expression is repressed or silenced. 
 
3.2. Promoter activity of the 5’-flanking region of the Sptrx genes 
Genomic sequences corresponding to the 5’-flanking regions of mouse Sptrx-1, Sptrx-2 and 
Sptrx-3 genes were identified and cloned into the promoterless pGL-3 basic vector (Fig. 1). 
These 5’-flanking regions ranged from –1 to –4kb upstream the initiation codon of each Sptrx 
gene. Reverse orientations of the –4kb fragments were also included as negative controls. Next, 
the ability of each fragment to promote transcription was evaluated by means of a luciferase 
reporter gene assay in GC-2spd(ts) cells. The experiments were initially carried out at both 37ºC 
and 32ºC. However, as no difference was found in the promoter activity (data not shown), we 
decided to perform additional experiments only at 37ºC. 
The results presented in Fig. 2 indicate considerable differences among the promoter 
activities of the 5’-flanking regions of the three Sptrx genes. Thus, while the Sptrx-1 –1kb region 
did not display any promoter activity compared with the empty vector, the promoter activities of 
the Sptrx-2 and Sptrx-3 –1kb regions were significantly higher than the control, being maximal 
in the case of Sptrx-2. Further differences appeared when we expanded the analysis to –2kb 
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regions. Hence, the Sptrx-1 –2kb fragment resulted in maximal promoter activity while, 
conversely, the Sptrx-2 –2kb fragment significantly reduced that obtained with its corresponding 
–1kb region. In contrast, the Sptrx-3 –2kb region did not display any statistically significant 
change of the promoter activity obtained with the –1kb alone. Noteworthy, the –4kb region of 
Sptrx-3 displayed the maximal promoter activity, while the equivalent region of both Sptrx-1 
and Sptrx-2 5’-flanking regions showed no significant luciferase activity compared with the 
empty vector. 
In addition to GC-2spd(ts), we transfected two other non-related mouse cell lines, Hepa1-6 
(hepatoma) and Y-1 (adrenal gland). In these two non-spermatogenic mouse cell lines, the 
luciferase activities of the Sptx-1, Sptrx-2 and Sptrx-3 constructs were essentially the same as in 
the GC-2spd(ts) cells (Supplemental Data Fig. 1). Only the Sptrx-3 –4kb construct revealed a 
significant difference showing as low promoter activity as those of the –2kb and –1kb regions in 
these two cell lines (Supplemental Data Fig. 1). Collectively, the results obtained in Hepa1-6 
and Y-1 cells are mostly consistent with the Sptrx null expression profiles observed in GC-
2spd(ts) since we did not find any clear differences among the three cell lines. On the other 
hand, the –2kb distal regions (between –2kb and –4kb) of both Sptrx-1 and Sptrx-2 5’-flanking 
regions seem to account for a transcriptional silencing of these genes in the cell lines used in the 
study. The situation is reversed for the Sptrx-3 promoter in GC-2spd(ts) cells, as the distal 
sequence present in the –4kb construct resulted in the highest promoter activity. 
To gain more insight into the molecular mechanisms influencing the Sptrx transcriptional 
activities, we decided to analyze more in detail the distal 5’-flanking regions of Sptrx-1, Sptrx-2 
and Sptrx-3 genes. Therefore, we made new constructs with the 2kb distal regions (from –2kb to 
–4kb from ATG) of Sptrx-1 and Sptrx-2 (Fig. 1) to investigate their ability to abolish any 
transcriptional activity. Also, we included as additional negative control the reverse orientations 
of those sequences that rendered the highest activity in the previous experiments (–2kb reverse 
for Sptrx-1 and –1kb reverse for Sptrx-2, Fig. 2). Finally, we designed a new –3kb construct for 
Sptrx-3 (Fig. 1) to check whether promoter activity of its 5’-flanking region increases with 
sequences longer than –2kb. To shorten the analysis we restricted the study to GC-2spd(ts) cell 
line due to the lack of clear differences with Hepa1-6 and Y-1 cell lines in the luciferase assays.   
As shown in Fig. 2, Sptrx-1 and Sptrx-2 –2kb distal regions exhibited null promoter activity, 
being even lower than that of the empty pGL-3 basic vector. Interestingly, while the reverse 
orientation of the –2kb and –4kb regions of Sptrx-1 showed no activity as expected, the reverse 
–1kb and –4kb regions of Sptrx-2 displayed significant promoter activities (Fig. 2). Surprisingly, 
the –3kb region of Sptrx-3 did not show any promoter activity (Fig. 2) suggesting the presence 
of a silencing regulatory element in the –2kb to –3kb fragment. 
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Taken together, these results indicate the existence of different mechanisms of transcriptional 
regulation for each Sptrx gene. First, the –2kb distal region of Sptrx-1 appears to be responsible 
for a strict transcriptional repression; however the lack of promoter activity within the –1kb 
region may imply other regulatory mechanisms in the proximal –2kb region, which may be 
considered to contain the core promoter for Sptrx-1 (Fig. 2). Second, the –1kb fragment of 
Sptrx-2 displayed the maximal promoter activity and therefore we propose this region to be the 
core promoter for Sptrx-2; furthermore, although the –2kb distal region seems to play a role in 
the transcriptional repression, we cannot exclude other regions between –1kb to –2kb 
participating in this negative regulation (Fig. 2). Third, since all the Sptrx-3 5’-flanking regions 
displayed significant promoter activity except for the –3kb construct, it is plausible to consider 
the core promoter for Sptrx-3 to be located in the –1kb fragment; the existence of potential cis-
regulatory elements in the –2kb to –3kb interval as well as distal enhancer sequences in the –3kb 
to –4kb interval are also suggest by our results (Fig. 2). 
 
3.3. Sequence analysis of the 5’-flanking region of the Sptrx genes 
The 5’-flanking regions of the Sptrx genes were used to localize putative promoter sequences, 
cis-regulatory modules and other significant elements using the Eldorado program included in 
the GenomatixSuite 3.1.1 software (http://www.genomatix.de/). The output forms from this 
analysis are summarized in Fig. 3. Core promoters are predicted to be localized within regions 
of about 600 bp in the first 1.5kb from ATG where different regulatory modules are located: 
EGRF/NFAT (-1091 to –1113) and glucocorticoid responsive element/Nuclear Factor 1 (-767 to 
–804) in the Sptrx-1 promoter; interferon regulatory factor/ETS1 (-655 to –678) in the Sptrx-2 
promoter and BRAC/HOX (-407 to –437), HOX/mouse Krueppel-like factor (-404 to –429) and 
enhancer CCAAT binding factor/SREBP1 (-229 to –259) in the Sptrx-3 promoter. Furthermore, 
two repetitive regions were found: one of 1206 bp in the Sptrx-2 5’-flanking region and another 
one of 4394 bp in the Sptrx-3 5’-flanking region. 
In addition, we used the MatInspector program included in GenomatixSuite 3.1.1 software 
(http://www.genomatix.de/) to look for putative transcription factor binding sites in the –1kb 
region from the ATG of each Sptrx 5’-flanking region. The most significant binding sites are 
listed in Table 1 and it is noteworthy that the analysis did not retrieve any TATA-box within the 
–1kb region of Sptrx-1. The fact that Sptrx-1 –1kb construct does not show any promoter 
activity (Fig. 1) may be related to the lack of any TATA-box within this region or the presence 
of the EGRF/NFAT regulatory module outside the –1kb region. 
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3.4. Testicular Sptrx mRNA molecule numbers  
Initial studies on mouse Sptrx mRNA expression patterns were based on qualitative multiple-
tissue northern blots and in situ hybridization analyses [13, 15, 16]. Here, we used a 
quantitatively rigorous approach based on reverse transcription followed by real-time PCR 
amplification [23] to provide for the first time a valuable new information on the steady-state 
copy numbers of the three murine Sptrx-1, Sprtx-2 and Sptrx-3 transcripts. 
We first wanted to know how the mouse male fine-tunes the number of testicular mRNA 
molecules during aging. Therefore, two primer pairs were initially designed per each Sptrx gene. 
These primers amplify a proximal or distal sequence away from the corresponding 5´-UTR 
(Table 2). For comparison, transcript levels for the novel form of thioredoxin/glutathione 
reductase (TGR) and for the cytosolic thioredoxin system (Trx1 and TrxR1) were quantified in 
parallel. 
As shown in Table 3, vast differences in transcript abundance depending on the primer pair 
were found for two (Sptrx-1 and Sptrx-3) out of the three investigated Sptrx genes. Remarkably, 
in 7-week-old animals, SPT1.5 that amplifies part of the sequence encoding the C-terminal 
thioredoxin domain, quantified only 9.4 % (82 vs 876 molecules/pg) of the Sptrx-1 mRNA 
molecules given by SPT1.2, which amplifies the fragment containing the proposed start codon 
[13]. Regarding the primer pair used for quantification of Sptrx-3 mRNA, SPT3.6 located in 
exons 5 and 6 quantified only 4.2 % (4.7 vs 111 molecules/pg) of the molecules determined by 
means of SPT3.1 that is located in exons 1 and 2 [16]. In clear contrast to what occurs in Sptrx-1 
and Sptrx-3 mRNA quantification, SPT2.1 that amplifies most of the sequence encoding the N-
terminal thioredoxin domain of Sptrx-2, yielded the same number of mRNA molecules as 
SPT2.2 (294 vs 273 molecules/pg), which amplifies part of the sequence encoding its first 
complete NDP-kinase domain. 
With respect to the temporal expression pattern of the Sptrx mRNAs (Table 3), outstanding 
findings are as follows: (i) While the Sptrx-1 transcripts were at appreciable levels in testes from 
animals of all examined ages [from pre-pubertal (1/2-week-old) to adult (4- to 7-week-old) 
mice], Sptrx-2 and Sptrx-3 mRNAs were basically restricted to the post-pubertal testis. (ii) 
Nonetheless, the Sptrx-1 mRNA was infrequently expressed in pre-pubertal testis, standing for < 
0.3 % of the adult amounts. (iii) Adult testes of different ages displayed significant different 
levels of Sptrx-1, Sptrx-2 and Sptrx-3 mRNAs (data from SPT1.2, SPT2.1 and SPT3.1 primer 
pairs, respectively); the amounts of mRNA in 4/5-week-old testes accounted for about 50% of 
the mRNA molecules quantified in 7-week-old testes. (iv) Primer-associated differences in 
Sptrx-1 and Sptrx-3 mRNA levels increased as the animals aged. For instance, SPT1.5 
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quantified most of the Sptrx-1 mRNA molecules given by SPT1.2 in pre-pubertal testes, 
whereas in adult mice, 4/5 and 7-weeks of age, SPT1.5 quantified only 18% and 9.4%, 
respectively, of the molecules determined by means of SPT1.2. 
Conversely to the age-associated differences in testicular Sptrx mRNA levels, Trx1 and 
TrxR1 transcript amounts remained basically unchanged as the animals aged. Interestingly, 
however, TGR mRNA abundance was reduced in young animals, particularly in pre-pubertal 
1/2-week-old mice, similar to the situation with Sptrx mRNAs. Although Trx1, TrxR1 and TGR 
transcripts are all present in testis, only TGR mRNA is highly overproduced in this organ as 
compared to other mouse tissues [25].  
 
3.5. Primer-Associated Differences in Testicular mRNA Levels 
The unforeseen differences found in association with the primer pair used for quantification 
of Sptrx-1 and Sptrx-3 mRNAs (Table 3), were further investigated by designing additional 
primer pairs (Table 2). For comparison, a new SPT2.3 primer pair was also designed for 
quantification of Sptrx-2 mRNA molecules. To shorten the analysis, quantifications were made 
in a unique sample of testicular RNA pooled from 9 out of the 12 mice of 7 weeks of age. 
As shown in Table 4, the highest number of Sptrx-1 mRNA molecules (1226 molecules/pg) 
was determined by means of SPT1.2. Primer pairs located either up- or down-stream of SPT1.2 
quantified only part of the Sptrx-1 transcripts. Thus, SPT1.1 detected 66 % (814 molecules/pg) 
of the maximal Sptrx-1 mRNA molecules given by SPT1.2. This finding indicates that, while 
methionine 4, chosen as the start site [13], is encoded by all Sptrx-1 transcripts, 44 % of them 
lack codons for the alternative potential starts methionine 2 and 3. With respect to those primer 
pairs (SPT1.3 to SPT1.7) located downstream of SPT1.2, an outstanding progressive reduction 
was detected in Sptrx-1 mRNA abundance, running in the 5´- to 3´ direction. This finding 
indicates that < 10 % of all Sptrx-1 transcripts quantified by means of SPT1.2, contain the 
sequence encoding the C-terminal thioredoxin domain, where SPT1.5 to SPT1.7 are located (see 
Table 2). Such a striking accumulation of truncated Sptrx-1 transcripts is consistent with 
premature transcription termination and/or transcript degradation, and it may be related to the 
extremely short 3´-UTR exhibited by both mouse and human Sptrx-1 mRNAs [12, 13]. 
With regard to Sptrx-3 mRNA, data in Table 4 indicate that whereas exons 1 to 4 are present 
in all transcript molecules (SPT3.1, SPT3.2 and SPT3.3 data), exon 5 (SPT3.4) or exon 6 
(SPT3.5) are present in a rather small percentage (12 % each) of total molecules. In agreement 
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with data in Table 3, exons 5 and 6 (SPT3.6) were simultaneously present only in 4 % of Sptrx-3 
mRNAs. 
In contrast to the above referred findings on Sptrx-1 and Sptrx-3 mRNAs, similar number of 
transcript copies (at about 270 molecules/pg) was determined by the three (SPT2.1, SPT2.2 and 
SPT2.3) primer pairs designed for quantification of Sptrx-2 mRNA. 
 
3.6. Tissue Distribution of Sptrx mRNA 
As previously mentioned, initial multiple-tissue northern blots identified adult testis as the 
only organ expressing Sptrx-1, Sptrx-2 and Sptrx-3 mRNAs [6], with no hybridization signal 
being obtained in any other tissue despite the use of low stringency conditions and extended 
exposure time. Given the sensitivity and reproducibility of real-time PCR for absolute 
quantification of Sptrx mRNA levels in vivo (Table 3), we further quantified the actual copy 
numbers of Sprtx-1, Sprtx-2 and Sprtx-3 mRNAs in a variety of adult (7-week-old) tissues other 
than testis. Total Sptrx-2 and Sptrx-3 mRNAs were quantified by means of SPT2.1 and SPT3.1 
pair primers, respectively. With regard to Sptrx-1, maximal transcript amounts were quantified 
by means of SPT1.2, and the specific percentage retaining the sequence for the C-terminal 
thioredoxin domain by SPT1.5. We confirmed the testis-specific expression pattern of Sptrx-2 
and Sptrx-3 genes, since their transcripts were nearly absent (≤ 0.001 molecules/pg) in lung, 
heart, brain, liver, kidney, spleen and ovary. However, in contrast to previous findings, Sptxr-1 
transcripts were present not only in testis (876 molecules/pg in Table 3) but also in lung, heart 
and brain (although at very low levels of about 0.07 molecules/pg), and to a higher extent in 
ovary (6.3 molecules/pg). Interestingly, when only considering those Sptrx-1 transcripts 
containing the sequence for the C-terminal domain, the ovary level (3.3 molecules/pg) 
constituted 4% of the amount quantified in testis (82 molecules/pg in Table 3). In agreement 
with this wider expression pattern of Sptrx-1, examination of EST sequences revealed its 
presence in cDNA from unfertilized egg and embryo, corresponding approximately to 11% of 
all available mouse Sptrx-1 EST. In contrast, Sptrx-2 and Sptrx-3 sequences were detected in 
EST exclusively from testes. 
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4. DISCUSSION 
Regulation of gene expression during spermatogenesis is exerted according to a complex and 
coordinated scheme where different cis-acting and trans-acting elements converge to either 
activate, modify or silence the expression of a particular group of specific genes responsible for 
the formation of a specialized cell as the spermatozoon. Among those gene products 
participating in the spermatogenic process we have recently identified three sperm-specific 
thioredoxins [6]. Since control of redox imbalance has been reported to be important in both the 
physiology of normal spermatogenesis and the aetiology of some spermatogenic abnormalities 
[26], regulation of Sptrx gene expression is likely to be of great importance.  
Sptrx proteins are expressed either in different structures within the sperm cell or at different 
stages of sperm development [6] and, therefore, the regulation of their specific expression 
pattern should differ for each Sptrx gene. We first investigated the transcription initiation of the 
Sptrx genes by promoter analysis of their respective 5’-flanking regions, ranging from –1kb to –
4kb, because distal regulatory regions are frequently responsible of cell type-specific expression 
[27, 28]. Experiments were carried out in the mouse spermatogenic GC-2spd(ts) cell line, where 
a recent study has identified the regulatory factor X2 to activate transcription of the testis-
specific histone Ht1 gene [29]. Although, neither Sptrx proteins nor mRNAs are found in GC-
2spd(ts) cells we completed the promoter analysis as a first approach to establish which 
fragments in the 5’-flanking regions are responsible for the transcriptional silencing of Sptrx 
genes in GC-2spd(ts) cells and somatic cell lines.  
In silico analyses and luciferase assays indicate that the putative promoters for all Sptrx genes 
must be contained in the –1.5kb proximal region from their respective ATG codons, where 
different regulatory elements are predicted to be located. However, the Sptrx-1 –1kb region, 
lacking any TATA-box, does not show promoter activity. One could speculate that the 
EGRF/NFAT module (located at –1091 to –1113) is essential for the activity because the Sptrx-
1 –2kb region, which contains this module, indeed exhibits the highest activity. Besides, the –1-
2kb region, apart from harbouring three predicted TATA-boxes at –1163, –1294 and –1752, 
contains several transcription binding-sites (data not shown), which may be functional to 
activate Sptrx-1 transcription. Also, the presence of a 525 bp intron within the 5’-UTR of Sptrx-
1 [13] suggests that the transcription initiation site, and therefore other cis-regulating sequences 
necessary for transcriptional initiation of Sptrx-1, should be located upstream of this intron (–
639bp from the ATG codon). 
 14
Importantly, the Sptrx-1 and Sptrx-2 –2kb distal regions may function as transcriptional 
silencers since –4kb constructs lack any promoter activity being even lower than pGL-3 basic 
empty vector basal activity. Since it is known that methylation status of CpG dinucleotides in 
CpG-poor promoters is important for transcriptional silencing [30-32], we made a prediction for 
CpG islands in the Sptrx 5’-flanking regions using the CpG island finder from EMBOSS tools 
(http://www.ebi.ac.uk/emboss/). One CpG island in the Sptrx-1 and three in the Sptrx-2 (but 
none in Sptrx-3) –2kb distal regions were found, suggesting that the status of these predicted 
CpG islands might play a role on the somatic transcriptional silencing of Sptrx-1 and Sptrx-2 
genes. 
The Sptrx-3 transcriptional repression seems to be regulated in a completely different way 
than that of Sptrx-1 and Sptrx-2. The fact that neither Sptrx-3 mRNA nor protein are found in 
GC-2spd(ts) cells while Sptrx-3 constructs (except the –3kb construct) exhibit promoter activity, 
raises an apparent contradiction. One explanation can be a silencing sequence  located in the 3’-
flanking region as occurs in other genes such as the murine CD46 [33]; however, additional 
experiments are required to support such a notion. On the other hand, the Sptrx-3 1kb distal 
region (–3-4kb from ATG) is likely to contain an upstream activating sequence from where 
spermatogenic-specific factors may enhance Sptrx-3 transcription. In fact, the Sptrx-3 1kb distal 
region alone does not show any promoter activity (data not shown) and therefore is not able to 
direct Sptrx-3 transcription by itself. Nonetheless, our results indicate that the presence of this 
region in –4kb Sptrx-3 constructs can increase the promoter activity in GC-2spd(ts) cells, but not 
in Y-1 or Hepa1-6 cells. 
Apart of transcription initiation regulation, we have also investigated how the steady-state 
Sptrx mRNA amounts change during mouse development and whether post-transcriptional 
mechanisms can affect Sptrx gene expression. We performed real-time PCR in whole-animal 
experiments, which revealed interesting new features about Sptrx transcription patterns. Sptrx-1 
mRNA is detected in testes from pre-pubertal animals (1-2 weeks) although at very low levels. 
In contrast, Sptrx-2 and Sptrx-3 mRNA are first identified after puberty (4-5 weeks and 
onwards) as described before [15, 16]. In addition, Sptrx-1, Sptrx-2 and Sptrx-3 mRNA levels in 
adult testes are significantly different and increase when animals age. 
We also found vast primer-associated differences for expression of Sptrx-1 and Sptrx-3, 
which increased with age as well.  Several mechanisms have been described to operate during 
spermatogenesis such as different transcription start site usage, mRNA degradation and 
alternative splicing [21] and it is possible that some of these mechanisms may explain these 
disparities. 
 15
For Sptrx-1, differences in results with SPT1.1 and SPT1.2 primer pairs may be explained by 
the existence of several transcription start sites upstream and downstream the SPT1.1 annealing 
sequence. As SPT1.1 amplifies about 2/3 of the total transcripts that SPT1.2 does, major 
transcription start site/s should be located downstream of the SPT1.1 annealing sequence. On the 
other hand, a main feature of the Sptrx-1 gene is the presence of only one intron in the 5´-UTR 
region, between potential start methionine 3 and 4. Regulatory sequences within this intron 
might also explain the lower amount of Sprtx-1 transcript molecules quantified by SPT1.1 as 
compared to SPT1.2. Conversely, differences between SPT1.2 and SPT1.3 compared to SPT1.7 
may be related to mRNA degradation or shortening at the 3’-end, a mechanism that has been 
proposed to play a key role in the control of gene expression [34]. This degradation mechanism 
may be associated to the particularly short 3’-UTR of 17bp of mouse Sptrx-1 [17]. Interestingly, 
we found that only <10% of all Sptrx-1 transcripts retain the C-terminal thioredoxin domain and 
thereby their functionality. 
With regard to the Sptrx-3 primer-associated differences, we hypothesize that two major 
mechanisms may operate in this case: mRNA degradation at the 3’-end and alternative splicing 
within Sptrx-3 exon 5. Although ∆5-Sptrx-3 splicing variant has not been identified in humans 
[16], we cloned this splicing variant from a mouse testis cDNA library (Clontech). Thus, the 
primer pair SPT3.4 can detect full-length transcripts and also partially degraded mRNAs, 
whereas SPT3.5 amplifies full-length transcripts and ∆5-Sptrx-3 spliced variants and SPT3.6 
detecting all the full-length non-degraded Sptrx-3 mRNAs. Taken together, and considering as 
functional only those mRNAs amplified by the SPT3.5 pair (full-length and ∆5-Sptrx-3), it 
seems that on an average of about 125 Sptrx-3 transcripts per pg of total RNA, no more than 
11.9% are functional, corresponding 8.2% to the more abundant ∆5-Sptrx-3 transcripts and only 
3.7% to full-length transcripts. 
In conclusion, these results indicate that transcription of Sptrx genes is exquisitely regulated 
and that the developing spermatozoon needs to fine-tune the expression of these genes to 
complete its development. This work constitutes an initial analysis of Sptrx genes transcription 
regulation and additional experiments in a more physiological context such as promoter analyses 
by in vivo electroporation [35] are envisaged to complement the present work. 
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FIGURE LEGENDS 
 
Fig. 1. Diagram of the constructs used in the luciferase assays. 5’-flanking regions from 
ATG of Sptrx genes were inserted upstream of a firefly luciferase reporter gene. RO, reverse 
orientation; U, upstream. 
 
Fig. 2. Promoter activity of Sptrx 5’-flanking regions in GC-2spd(ts) cells. Different 5’-
flanking region constructs (Fig. 1) of Sptrx-1, Sptrx-2 and Sptrx-3 were used in a luciferase 
reporter gene assay in GC-2spd(ts) cells. “n. t.”, non transfected. Bars indicate mean ± SEM 
with data expressed as percentage of promoter activity compared to that of the pGL-3 empty 
vector. Comparisons among constructs were performed using ANOVA followed by the Student-
Newman-Keuls post-hoc test (N=3-6, P<0.05). Statistical significant differences with respect to 
pGL-3 empty vector are indicated with an asterisk.  
 
Fig. 3. Schematic representation of Sptrx 5’-flanking regions. Predicted promoter sequences, 
regulatory modules and repetitive sequences are drawn for each Sptrx gene according to the 
output forms from GenomatixSuite 3.1.1 software (http://www.genomatix.de/). 
 
Supplemental Data Fig 1. Promoter activity of Sptrx 5’-flanking regions in GC-2spd(ts), 
Hepa1-6 and Y-1 cell lines. Different constructs of Sptrxs 5’-flanking regions (Fig. 1) were 
used in a luciferase reporter gene assay in Hepa1-6 (white bars), Y-1 (grey bars) and GC-
2spd(ts) (black bars) cells. “n. t.”, non transfected. Bars indicate mean ± SEM with data 
expressed as percentage of promoter activity compared to that of the pGL-3 empty vector. 
Comparisons among constructs were performed using ANOVA followed by the Student-
Newman-Keuls post-hoc test (N=3-6, P<0.05). Statistical significant differences with respect to 
pGL-3 empty vector are indicated with an asterisk. No significant differences are indicated as 
“n. s.” 
 
 
Table 1. Putative transcription binding sites in –1kb 5’-flanking regions of Sptrx 
genes 
 
5’-flanking  
region 
Transcription 
 binding site 
nt position 
from ATG 
AP-4 -840 
GC-box -611 
Basic Krueppel-like factor -613 
AREB-6 -383 
c-Myc/Max -349 
v-Myb -323 
MEF-2 -226 
MSX-1 and MSX-2 -145, -137 
Sptrx-1 
Retinoic acid receptor -23 
GC-box -962 
MAZ binding site -960, -758 
TATA-box -518 
Octamer binding factor -487 
Nuclear factor Y -312 
Binding site for S8 type homeodomains -309 
HOX-1.3 -274 
CCAAT/enhancer binding protein -195 
Sptrx-2 
Activating transcription factor -161 
SP-1 like transcription factor TIEG -991 
BRN-2 -971, -935, 
-931, -809 
MEF-2 -957, -945 
TATA-box -805, -563, 
-184 
Prostate-specific homeodomain protein NKX3.1 -799 
TG-interacting factor -756 
GATA-3 -755, -616, 
-376 
GATA-1 -592, -270 
NFAT -581 
BTE binding protein -515 
NF-kappaβ -513 
CCAAT/enhancer binding protein -479 
Binding site for S8 type homeodomains -435 
Nuclear factor Y -128 
Sptrx-3 
CCAAT-box -128 
 
Table 1
Table 2. Primers used for quantification of mRNA molecules 
 Primers 
Target 
(GenBank) Primer 
pair name 
Sequencea 5'-position Exonb 
 
Fragment 
size (bp)c 
Sptrx-1 SPT1.1 
5´-AAAGAATAAGGACAAGGGGCTGGACATGAAC-3’ (F) 
5´-CTTTCATTTGCTTTTCCTCCGTTGTTGAGTG-3’ (R) 93 
191 
1 
1 
99 
SPT1.2 5´-TGAAAGGGGCAGCAACGAAAATCCATTAC-3’ (F) 
5´-GGACGGTATTCTCTGAAAACATGGGGGTG-3’ (R) 
186 
385 
1-2 
2 
200 
SPT1.3 5´-TCTAAATCCTCGGGCTACTCCAAGCAGAC-3’ (F) 
5´-CGTTGCAGGCTTGAGGGTGCTC-3’ (R) 
451 
555 
2 
2 
105 
SPT1.4 5´-GACAGCGTTCAGTCAAAGGAGAGTGAAGA-3’ (F) 
5´-TTCCTGGGACTGGATGGTGTCTTCTTC-3’ (R) 
1096 
1293 
2 
2 
198 
SPT1.5 5´-TTGGAGCAGAAATAGAGACCCTGGAGGAAG-3’ (F) 
5´-CCACCAGCTTCTCTCCAGCGTCTTTG-3’ (R) 
1355 
1456 
2 
2 
102 
SPT1.6 5´-TTGGAGCAGAAATAGAGACCCTGGAGGAAG-3’ (F) 
5´-GGGAGGTGAAAGATCTCACAGTCTTGCAC-3’ (R) 
1355 
1610 
2 
2 
256 
(AF196282) 
SPT1.7 5´-TTTGAAGCACGAGGATGTGATATTCTTGGAG-3’ (F) 
5´-ACAAGGGCACCAGAAAATTCACCCAC-3’ (R) 
1524 
1667 
2 
2 
144 
Sptrx-2 SPT2.1 5´-CAAAAAGCGTGAAGTCCAGCTACAGTCAGTC-3’ (F) 
5´-TTCAGCAACGACGAAGTGAAGAATCTCATC-3’ (R) 
150 
345 
2-3 
4-5 
196 
SPT2.2 5´-GTGAGGAAGAGAAAGATGACGTGTTGAACG-3’ (F) 
5´-ATGGATCTTGCACACTGTTCTTGCTTCTTC-3’ (R) 
1112 
1227 
11-12 
12 
116 (AF548543) 
SPT2.3 5´-AGCCTC ATGTGACACACAAAGAAAGAATGG-3’ (F) 
5´-ACCATGACTAGCGACATGCCCAAAGATAAG-3’ (R) 
1505 
1697 
14-15 
15-16 
193 
Sptrx-3 SPT3.1 5´-CAGCAGCAAGTCCCAGATGTTAATCATGGT-3’ (F) 
5´-TTGTTTCCAGCATCGCTGAACAATTCTTTC-3’ (R) 
49 
135 
1 
2 
87 
SPT3.2 5´-TGAAAGAATTGTTCAGCGATGCTGGAAAC-3’ (F) 
5´-AGATGAGTCCACATCCACCTGAGCAAAC-3’ (R) 
105 
259 
2 
3 
155 
SPT3.3 5´-GCTTGTGGTGGTAGAGTTTTCAGCAAAGTG-3’ (F) 
5´-ATCTGGAATGTGGGTAGCATTGTGATGTC-3’ (R) 
136 
309 
2 
4 
174 
SPT3.4 5´-AAAATGTCACGTTTGCTCAGGTGGATGTG-3’ (F) 
5´-CTTCGGTCCACTTCTGAGGCAGCAC-3’ (R) 
222 
385 
3 
5 
164 
SPT3.5 5´-AAA ATGTCACGTTTGCTCAGGTGGATGTG-3’ (F) 
5´-TTTCCAGTTGTTTAGCATCAGCTCCATGACA-3’ (R) 
222 
434 
3 
6 
213/147 
(AY495589) 
SPT3.6 5´-GCTGCCTCAGAAGTGGACCGAAGAG-3’ (F) 
5´-CATGCAAGACACAGAGCATTAGCTCCTG-3’ (R) 
363 
521 
5 
6 
 
159 
aSequences of forward (F) and reverse (R) primers. 
bExon numbers were according to NCBI Evidence Viewer, except those for Sptrx-3 that were according to [16]. 
cEach primer pair generates a single PCR fragment. The exception is SPT3.5 that generates two fragments, the 
shortest of 147 bp lacking exon 5. 
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Table 3. Age-associated differences in testicular mRNA levels 
Transcripts were quantitated in testes from n mice of different ages. Primers for 
amplification of Sptrx-1, Sptrx-2 and Sptrx-3 are given in Table 1, and those for 
TGR, Trx1 and TrxR1 in [25]. Data are the means ± S.E. of mRNA molecules per 
pg of total RNA. Comparisons among mouse groups were done using ANOVA 
followed by the Student-Newman-Keuls test. Comparisons between primers were 
done using the Student’s t test. Average values with the same superscript are not 
statistically different (P > 0.05). 
 
 Age 
 Target 
Primer pair  
1/2 weeks 
(n = 6)  
4/5 weeks 
(n = 6)  
7 weeks 
(n = 12)  
 
Sptrx-1        
 
SPT1.2  0.22 ± 0.016a  369 ± 23  876 ± 38  
 
SPT1.5  0.19 ± 0.016a  65 ± 8.7  82 ± 2.4  
 
Sptrx-2        
 
SPT2.1  0.005 ± 0.001b  198 ± 4.5c  294 ± 15d  
 
SPT2.2  0.007  ± 0.001b  211 ± 5.6
c  273 ± 18d  
 
Sptrx-3        
 
SPT3.1  ≤ 0.001  60 ± 4.0  111 ± 4.2  
 
SPT3.6  ≤ 0.001  5.5 ± 0.70e  4.7 ± 0.68e  
         
 TGR  26 ± 2.2  382 ± 26  506 ± 13  
 
Trx1  87 ± 1.7f  76 ± 13f  65 ± 3.1f  
 
TrxR1  11 ± 0.56  28 ± 3.4g  26 ± 1.8g  
         
 
 
Table 3
Table 4.  Primer-associated differences in testicular mRNA levels 
Transcripts were quantitated in a sample of total RNA pooled from testes of 9 out of 
the 12 mice of 7 weeks of age analyzed individually in Table 3. Primers are given in 
Table 1.  
 
Sptrx-1  Sptrx-3 
Primer pair molecules/pg  Primer pair molecules/pg 
SPT1.1 814   SPT3.1 114     
SPT1.2 1226   SPT3.2 118     
SPT1.3 698   SPT3.3 145     
SPT1.4 192   SPT3.4 16     
SPT1.5 79   SPT3.5 15     
SPT1.6 61   SPT3.6 4.7  
SPT1.7 48      
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